Enzo Health, a Lehi, Utah-based AI platform for home health and post-acute care providers, announced earlier in May that it raised $20 million in Series A funding, bringing its total funding to $26 million. The round was led by N47, with participation from existing investors Gradient, Tandem Ventures and Rigby Watts. The company said the financing will support the expansion of its AI-driven workflow platform into skilled nursing and hospice care as demand for home-based care continues to rise.
Founded in 2024, Enzo Health develops software that automates front-office, clinical, and back-office workflows for home health agencies, including referral intake, documentation, reimbursement, and compliance management. The company said its platform is currently used by organizations supporting more than 500,000 patients annually and that revenue increased more than 40x over the past year. Enzo’s products include AI-assisted clinical documentation, automated eligibility verification and chart-review tools designed to reduce regulatory and reimbursement risk for providers.
The financing comes as home health operators face growing administrative burdens tied to staffing shortages, reimbursement pressure and increased regulatory complexity. Enzo Health said part of the proceeds will be used to extend its platform into hospice and skilled nursing workflows, broadening its reach across the post-acute care market.
